Glucagon

CAS No.: 16941-32-5

Molecular formula: c153h225n43o49s

Molecular weight: 3482.75

EINECS No.: 685-611-6

indication:

The oral administration of this product is invalid, so more injections are given. The effect is short in vivo. It takes effect 5 minutes after intravenous injection, and the blood sugar can increase 50% in 30 minutes. The effect can last for about 1 hour. It is mainly inactivated in liver, kidney and plasma. The half-life of plasma is 3-6 minutes. It is clinically used in patients with severe hypoglycemia coma and inability to eat. It is also used to measure pancreatic function and assist in the diagnosis of islet tumor and pheochromocytoma. Circulatory system is mainly used for acute heart failure, heart failure with digitalis treatment failure, heart failure with cardiogenic shock. The curative effect of glucagon on chronic heart failure is poor. The main indications are as follows: ① acute low emission syndrome. ② Acute heart failure or cardiogenic shock caused by coronary heart disease and cardiomyopathy. ③ Combined with propranolol in the treatment of arrhythmia caused by digitalis poisoning.